aminolevulinic acid has been researched along with Delayed Effects, Prenatal Exposure in 5 studies
Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A previously conducted study of prenatal lead exposure and schizophrenia using delta-aminolevulinic acid, a biologic marker of Pb exposure, in archived maternal serum samples collected from subjects enrolled in the Childhood Health and Development Study (1959-1966) based in Oakland, California, suggested a possible association between prenatal Pb exposure and the development of schizophrenia in later life." | 7.74 | Prenatal exposure to lead, delta-aminolevulinic acid, and schizophrenia: further evidence. ( Bresnahan, M; Brown, AS; Buka, SL; Factor-Litvak, P; Goldstein, JM; Graziano, J; Groeger, J; McKeague, I; Opler, MG; Seidman, LJ; Susser, ES; Wei, C, 2008) |
| "Schizophrenia is a severe mental disorder of unknown etiology." | 5.32 | Prenatal lead exposure, delta-aminolevulinic acid, and schizophrenia. ( Brown, AS; Desai, M; Factor-Litvak, P; Graziano, J; Opler, MG; Schaefer, C; Susser, ES; Zheng, W, 2004) |
| "A previously conducted study of prenatal lead exposure and schizophrenia using delta-aminolevulinic acid, a biologic marker of Pb exposure, in archived maternal serum samples collected from subjects enrolled in the Childhood Health and Development Study (1959-1966) based in Oakland, California, suggested a possible association between prenatal Pb exposure and the development of schizophrenia in later life." | 3.74 | Prenatal exposure to lead, delta-aminolevulinic acid, and schizophrenia: further evidence. ( Bresnahan, M; Brown, AS; Buka, SL; Factor-Litvak, P; Goldstein, JM; Graziano, J; Groeger, J; McKeague, I; Opler, MG; Seidman, LJ; Susser, ES; Wei, C, 2008) |
| "Schizophrenia is a severe mental disorder of unknown etiology." | 1.32 | Prenatal lead exposure, delta-aminolevulinic acid, and schizophrenia. ( Brown, AS; Desai, M; Factor-Litvak, P; Graziano, J; Opler, MG; Schaefer, C; Susser, ES; Zheng, W, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsuo, K | 1 |
| Yabuki, Y | 1 |
| Fukunaga, K | 1 |
| Opler, MG | 2 |
| Buka, SL | 1 |
| Groeger, J | 1 |
| McKeague, I | 1 |
| Wei, C | 1 |
| Factor-Litvak, P | 2 |
| Bresnahan, M | 1 |
| Graziano, J | 2 |
| Goldstein, JM | 1 |
| Seidman, LJ | 1 |
| Brown, AS | 2 |
| Susser, ES | 2 |
| Desai, M | 1 |
| Zheng, W | 1 |
| Schaefer, C | 1 |
| Wang, J | 1 |
| Wu, J | 1 |
| Zhang, Z | 1 |
| Borella, P | 1 |
| Sturloni, N | 1 |
| Rovesti, S | 1 |
| Vivoli, R | 1 |
| Bargellini, A | 1 |
| Vivoli, G | 1 |
5 other studies available for aminolevulinic acid and Delayed Effects, Prenatal Exposure
| Article | Year |
|---|---|
5-aminolevulinic acid inhibits oxidative stress and ameliorates autistic-like behaviors in prenatal valproic acid-exposed rats.
Topics: Aminolevulinic Acid; Animals; Anticonvulsants; Autistic Disorder; Dose-Response Relationship, Drug; | 2020 |
Prenatal exposure to lead, delta-aminolevulinic acid, and schizophrenia: further evidence.
Topics: Aminolevulinic Acid; Biomarkers; Female; Humans; Lead; Pregnancy; Prenatal Exposure Delayed Effects; | 2008 |
Prenatal lead exposure, delta-aminolevulinic acid, and schizophrenia.
Topics: Adolescent; Adult; Aminolevulinic Acid; Biomarkers; Case-Control Studies; Female; Humans; Lead; Male | 2004 |
Oxidative stress in mouse brain exposed to lead.
Topics: Aminolevulinic Acid; Animals; Antioxidants; Brain; Female; Lactation; Mice; Mice, Inbred BALB C; Org | 2006 |
[Evaluation of the risk of neuropsychological damage from lead exposure in childhood].
Topics: Air Pollutants; Aminolevulinic Acid; Brain Damage, Chronic; Ceramics; Child; Environmental Exposure; | 1998 |